nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—ACHE—Irinotecan—lung cancer	0.144	0.235	CbGbCtD
Rivastigmine—BCHE—Irinotecan—lung cancer	0.0868	0.141	CbGbCtD
Rivastigmine—BCHE—Cisplatin—lung cancer	0.0708	0.115	CbGbCtD
Rivastigmine—CYP2D6—Gefitinib—lung cancer	0.0389	0.0634	CbGbCtD
Rivastigmine—CYP2D6—Vinorelbine—lung cancer	0.03	0.0488	CbGbCtD
Rivastigmine—CYP3A4—Topotecan—lung cancer	0.027	0.0441	CbGbCtD
Rivastigmine—CYP3A4—Gefitinib—lung cancer	0.0247	0.0403	CbGbCtD
Rivastigmine—CYP3A4—Teniposide—lung cancer	0.024	0.0391	CbGbCtD
Rivastigmine—CYP2D6—Erlotinib—lung cancer	0.023	0.0375	CbGbCtD
Rivastigmine—CYP3A4—Vinorelbine—lung cancer	0.019	0.031	CbGbCtD
Rivastigmine—CYP2D6—Vinblastine—lung cancer	0.0185	0.0301	CbGbCtD
Rivastigmine—CYP3A4—Crizotinib—lung cancer	0.0152	0.0247	CbGbCtD
Rivastigmine—CYP3A4—Erlotinib—lung cancer	0.0146	0.0238	CbGbCtD
Rivastigmine—CYP3A4—Paclitaxel—lung cancer	0.0134	0.0218	CbGbCtD
Rivastigmine—CYP3A4—Irinotecan—lung cancer	0.0132	0.0215	CbGbCtD
Rivastigmine—CYP3A4—Vinblastine—lung cancer	0.0117	0.0191	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—lung cancer	0.0113	0.0185	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—lung cancer	0.0106	0.0172	CbGbCtD
Rivastigmine—CYP3A4—Docetaxel—lung cancer	0.00968	0.0158	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—lung cancer	0.00721	0.0118	CbGbCtD
Rivastigmine—Neostigmine—ABCB1—lung cancer	0.000294	1	CrCbGaD
Rivastigmine—Photosensitivity reaction—Doxorubicin—lung cancer	6.3e-05	0.000201	CcSEcCtD
Rivastigmine—Oedema—Docetaxel—lung cancer	6.29e-05	0.0002	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—lung cancer	6.29e-05	0.0002	CcSEcCtD
Rivastigmine—Pruritus—Gemcitabine—lung cancer	6.27e-05	0.0002	CcSEcCtD
Rivastigmine—Urethral disorder—Methotrexate—lung cancer	6.26e-05	0.000199	CcSEcCtD
Rivastigmine—Infection—Docetaxel—lung cancer	6.25e-05	0.000199	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—lung cancer	6.25e-05	0.000199	CcSEcCtD
Rivastigmine—Feeling abnormal—Etoposide—lung cancer	6.24e-05	0.000199	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—lung cancer	6.23e-05	0.000198	CcSEcCtD
Rivastigmine—Diarrhoea—Irinotecan—lung cancer	6.23e-05	0.000198	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—lung cancer	6.19e-05	0.000197	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Etoposide—lung cancer	6.19e-05	0.000197	CcSEcCtD
Rivastigmine—Shock—Docetaxel—lung cancer	6.19e-05	0.000197	CcSEcCtD
Rivastigmine—Nervous system disorder—Docetaxel—lung cancer	6.17e-05	0.000196	CcSEcCtD
Rivastigmine—Thrombocytopenia—Docetaxel—lung cancer	6.16e-05	0.000196	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—lung cancer	6.16e-05	0.000196	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—lung cancer	6.16e-05	0.000196	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—lung cancer	6.16e-05	0.000196	CcSEcCtD
Rivastigmine—Visual impairment—Methotrexate—lung cancer	6.15e-05	0.000196	CcSEcCtD
Rivastigmine—Tachycardia—Docetaxel—lung cancer	6.14e-05	0.000195	CcSEcCtD
Rivastigmine—Feeling abnormal—Paclitaxel—lung cancer	6.12e-05	0.000195	CcSEcCtD
Rivastigmine—Skin disorder—Docetaxel—lung cancer	6.11e-05	0.000194	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	6.11e-05	0.000194	CcSEcCtD
Rivastigmine—Hypersensitivity—Cisplatin—lung cancer	6.09e-05	0.000194	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Paclitaxel—lung cancer	6.07e-05	0.000193	CcSEcCtD
Rivastigmine—Diarrhoea—Gemcitabine—lung cancer	6.07e-05	0.000193	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—lung cancer	6.05e-05	0.000193	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—lung cancer	6.04e-05	0.000192	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—lung cancer	6.04e-05	0.000192	CcSEcCtD
Rivastigmine—Dizziness—Irinotecan—lung cancer	6.02e-05	0.000192	CcSEcCtD
Rivastigmine—Urticaria—Etoposide—lung cancer	6.02e-05	0.000191	CcSEcCtD
Rivastigmine—Anorexia—Docetaxel—lung cancer	6e-05	0.000191	CcSEcCtD
Rivastigmine—Abdominal pain—Etoposide—lung cancer	5.99e-05	0.00019	CcSEcCtD
Rivastigmine—Body temperature increased—Etoposide—lung cancer	5.99e-05	0.00019	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—lung cancer	5.99e-05	0.00019	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—lung cancer	5.99e-05	0.00019	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—lung cancer	5.97e-05	0.00019	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—lung cancer	5.95e-05	0.000189	CcSEcCtD
Rivastigmine—Asthenia—Cisplatin—lung cancer	5.93e-05	0.000189	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—lung cancer	5.93e-05	0.000189	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—lung cancer	5.9e-05	0.000188	CcSEcCtD
Rivastigmine—Urticaria—Paclitaxel—lung cancer	5.9e-05	0.000188	CcSEcCtD
Rivastigmine—Hypotension—Docetaxel—lung cancer	5.88e-05	0.000187	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—lung cancer	5.87e-05	0.000187	CcSEcCtD
Rivastigmine—Abdominal pain—Paclitaxel—lung cancer	5.87e-05	0.000187	CcSEcCtD
Rivastigmine—Body temperature increased—Paclitaxel—lung cancer	5.87e-05	0.000187	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—lung cancer	5.82e-05	0.000185	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—lung cancer	5.81e-05	0.000185	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—lung cancer	5.79e-05	0.000184	CcSEcCtD
Rivastigmine—Vomiting—Irinotecan—lung cancer	5.79e-05	0.000184	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—lung cancer	5.78e-05	0.000184	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—lung cancer	5.75e-05	0.000183	CcSEcCtD
Rivastigmine—Rash—Irinotecan—lung cancer	5.74e-05	0.000183	CcSEcCtD
Rivastigmine—Dermatitis—Irinotecan—lung cancer	5.73e-05	0.000182	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Docetaxel—lung cancer	5.73e-05	0.000182	CcSEcCtD
Rivastigmine—Chills—Methotrexate—lung cancer	5.73e-05	0.000182	CcSEcCtD
Rivastigmine—Headache—Irinotecan—lung cancer	5.7e-05	0.000181	CcSEcCtD
Rivastigmine—Insomnia—Docetaxel—lung cancer	5.69e-05	0.000181	CcSEcCtD
Rivastigmine—Diarrhoea—Cisplatin—lung cancer	5.66e-05	0.00018	CcSEcCtD
Rivastigmine—Paraesthesia—Docetaxel—lung cancer	5.65e-05	0.00018	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—lung cancer	5.64e-05	0.00018	CcSEcCtD
Rivastigmine—Vomiting—Gemcitabine—lung cancer	5.64e-05	0.000179	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—lung cancer	5.63e-05	0.000179	CcSEcCtD
Rivastigmine—Dyspnoea—Docetaxel—lung cancer	5.61e-05	0.000179	CcSEcCtD
Rivastigmine—Somnolence—Docetaxel—lung cancer	5.59e-05	0.000178	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—lung cancer	5.59e-05	0.000178	CcSEcCtD
Rivastigmine—Rash—Gemcitabine—lung cancer	5.59e-05	0.000178	CcSEcCtD
Rivastigmine—Dermatitis—Gemcitabine—lung cancer	5.59e-05	0.000178	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—lung cancer	5.58e-05	0.000178	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—lung cancer	5.56e-05	0.000177	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—lung cancer	5.56e-05	0.000177	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—lung cancer	5.56e-05	0.000177	CcSEcCtD
Rivastigmine—Headache—Gemcitabine—lung cancer	5.56e-05	0.000177	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—lung cancer	5.54e-05	0.000176	CcSEcCtD
Rivastigmine—Dyspepsia—Docetaxel—lung cancer	5.54e-05	0.000176	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—lung cancer	5.53e-05	0.000176	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—lung cancer	5.53e-05	0.000176	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—lung cancer	5.5e-05	0.000175	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—lung cancer	5.49e-05	0.000175	CcSEcCtD
Rivastigmine—Decreased appetite—Docetaxel—lung cancer	5.47e-05	0.000174	CcSEcCtD
Rivastigmine—Hypersensitivity—Paclitaxel—lung cancer	5.47e-05	0.000174	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—lung cancer	5.46e-05	0.000174	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—lung cancer	5.45e-05	0.000173	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—lung cancer	5.44e-05	0.000173	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Docetaxel—lung cancer	5.43e-05	0.000173	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—lung cancer	5.43e-05	0.000173	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—lung cancer	5.43e-05	0.000173	CcSEcCtD
Rivastigmine—Fatigue—Docetaxel—lung cancer	5.43e-05	0.000173	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—lung cancer	5.42e-05	0.000172	CcSEcCtD
Rivastigmine—Nausea—Irinotecan—lung cancer	5.41e-05	0.000172	CcSEcCtD
Rivastigmine—Constipation—Docetaxel—lung cancer	5.38e-05	0.000171	CcSEcCtD
Rivastigmine—Pain—Docetaxel—lung cancer	5.38e-05	0.000171	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—lung cancer	5.38e-05	0.000171	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—lung cancer	5.36e-05	0.00017	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—lung cancer	5.33e-05	0.00017	CcSEcCtD
Rivastigmine—Asthenia—Paclitaxel—lung cancer	5.33e-05	0.000169	CcSEcCtD
Rivastigmine—Nausea—Gemcitabine—lung cancer	5.27e-05	0.000168	CcSEcCtD
Rivastigmine—Vomiting—Cisplatin—lung cancer	5.26e-05	0.000167	CcSEcCtD
Rivastigmine—Pruritus—Paclitaxel—lung cancer	5.25e-05	0.000167	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—lung cancer	5.24e-05	0.000167	CcSEcCtD
Rivastigmine—ACHE—Metabolism—B4GALT5—lung cancer	5.24e-05	0.000731	CbGpPWpGaD
Rivastigmine—Erythema multiforme—Doxorubicin—lung cancer	5.23e-05	0.000166	CcSEcCtD
Rivastigmine—Rash—Cisplatin—lung cancer	5.21e-05	0.000166	CcSEcCtD
Rivastigmine—Dermatitis—Cisplatin—lung cancer	5.21e-05	0.000166	CcSEcCtD
Rivastigmine—Feeling abnormal—Docetaxel—lung cancer	5.19e-05	0.000165	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—lung cancer	5.18e-05	0.000165	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—lung cancer	5.17e-05	0.000164	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—lung cancer	5.16e-05	0.000164	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—lung cancer	5.15e-05	0.000164	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Docetaxel—lung cancer	5.15e-05	0.000164	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	5.14e-05	0.000717	CbGpPWpGaD
Rivastigmine—Anaemia—Methotrexate—lung cancer	5.14e-05	0.000163	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—lung cancer	5.13e-05	0.000163	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—lung cancer	5.13e-05	0.000163	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTA4—lung cancer	5.09e-05	0.000711	CbGpPWpGaD
Rivastigmine—Diarrhoea—Paclitaxel—lung cancer	5.08e-05	0.000162	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	5.05e-05	0.000704	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.02e-05	0.000701	CbGpPWpGaD
Rivastigmine—Angiopathy—Doxorubicin—lung cancer	5.02e-05	0.00016	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—lung cancer	5.01e-05	0.000159	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—lung cancer	5.01e-05	0.000159	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—lung cancer	4.99e-05	0.000159	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—lung cancer	4.98e-05	0.000159	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.98e-05	0.000695	CbGpPWpGaD
Rivastigmine—Abdominal pain—Docetaxel—lung cancer	4.97e-05	0.000158	CcSEcCtD
Rivastigmine—Body temperature increased—Docetaxel—lung cancer	4.97e-05	0.000158	CcSEcCtD
Rivastigmine—BCHE—Metabolism—RRM1—lung cancer	4.97e-05	0.000693	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA3—lung cancer	4.97e-05	0.000693	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTA2—lung cancer	4.96e-05	0.000693	CbGpPWpGaD
Rivastigmine—Chills—Doxorubicin—lung cancer	4.96e-05	0.000158	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—lung cancer	4.94e-05	0.000157	CcSEcCtD
Rivastigmine—Dizziness—Paclitaxel—lung cancer	4.91e-05	0.000156	CcSEcCtD
Rivastigmine—Nausea—Cisplatin—lung cancer	4.91e-05	0.000156	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—lung cancer	4.89e-05	0.000155	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	4.88e-05	0.000681	CbGpPWpGaD
Rivastigmine—Cough—Methotrexate—lung cancer	4.85e-05	0.000154	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—MDM2—lung cancer	4.84e-05	0.000676	CbGpPWpGaD
Rivastigmine—Mental disorder—Doxorubicin—lung cancer	4.84e-05	0.000154	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	4.84e-05	0.000675	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—RAF1—lung cancer	4.83e-05	0.000674	CbGpPWpGaD
Rivastigmine—Convulsion—Methotrexate—lung cancer	4.82e-05	0.000153	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—lung cancer	4.81e-05	0.000153	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—lung cancer	4.81e-05	0.000153	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—lung cancer	4.81e-05	0.000153	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTA1—lung cancer	4.79e-05	0.000668	CbGpPWpGaD
Rivastigmine—Rash—Etoposide—lung cancer	4.77e-05	0.000152	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	4.77e-05	0.000666	CbGpPWpGaD
Rivastigmine—Dermatitis—Etoposide—lung cancer	4.77e-05	0.000152	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	4.75e-05	0.000663	CbGpPWpGaD
Rivastigmine—Headache—Etoposide—lung cancer	4.74e-05	0.000151	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—lung cancer	4.74e-05	0.000151	CcSEcCtD
Rivastigmine—ACHE—Metabolism—ABCC3—lung cancer	4.73e-05	0.000661	CbGpPWpGaD
Rivastigmine—Chest pain—Methotrexate—lung cancer	4.73e-05	0.000151	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—lung cancer	4.73e-05	0.000151	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—lung cancer	4.73e-05	0.000151	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—lung cancer	4.72e-05	0.00015	CcSEcCtD
Rivastigmine—Vomiting—Paclitaxel—lung cancer	4.72e-05	0.00015	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—lung cancer	4.71e-05	0.00015	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.7e-05	0.00015	CcSEcCtD
Rivastigmine—Rash—Paclitaxel—lung cancer	4.68e-05	0.000149	CcSEcCtD
Rivastigmine—Dermatitis—Paclitaxel—lung cancer	4.68e-05	0.000149	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—AZIN2—lung cancer	4.68e-05	0.000653	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—COL4A3BP—lung cancer	4.68e-05	0.000653	CbGpPWpGaD
Rivastigmine—Discomfort—Methotrexate—lung cancer	4.67e-05	0.000149	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—lung cancer	4.67e-05	0.000149	CcSEcCtD
Rivastigmine—BCHE—Metabolism—B4GALT5—lung cancer	4.67e-05	0.000652	CbGpPWpGaD
Rivastigmine—Back pain—Doxorubicin—lung cancer	4.66e-05	0.000148	CcSEcCtD
Rivastigmine—Headache—Paclitaxel—lung cancer	4.65e-05	0.000148	CcSEcCtD
Rivastigmine—Hypersensitivity—Docetaxel—lung cancer	4.64e-05	0.000148	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—lung cancer	4.63e-05	0.000147	CcSEcCtD
Rivastigmine—ACHE—Metabolism—AKR1C1—lung cancer	4.59e-05	0.00064	CbGpPWpGaD
Rivastigmine—Confusional state—Methotrexate—lung cancer	4.57e-05	0.000146	CcSEcCtD
Rivastigmine—BCHE—Metabolism—GSTA4—lung cancer	4.54e-05	0.000634	CbGpPWpGaD
Rivastigmine—Vision blurred—Doxorubicin—lung cancer	4.54e-05	0.000144	CcSEcCtD
Rivastigmine—Asthenia—Docetaxel—lung cancer	4.52e-05	0.000144	CcSEcCtD
Rivastigmine—Infection—Methotrexate—lung cancer	4.51e-05	0.000143	CcSEcCtD
Rivastigmine—Nausea—Etoposide—lung cancer	4.5e-05	0.000143	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—lung cancer	4.47e-05	0.000142	CcSEcCtD
Rivastigmine—Pruritus—Docetaxel—lung cancer	4.45e-05	0.000142	CcSEcCtD
Rivastigmine—ACHE—Metabolism—UGT1A1—lung cancer	4.45e-05	0.000621	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Methotrexate—lung cancer	4.45e-05	0.000142	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—lung cancer	4.45e-05	0.000142	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—lung cancer	4.44e-05	0.000141	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.44e-05	0.00062	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA2—lung cancer	4.43e-05	0.000618	CbGpPWpGaD
Rivastigmine—Agitation—Doxorubicin—lung cancer	4.42e-05	0.000141	CcSEcCtD
Rivastigmine—Nausea—Paclitaxel—lung cancer	4.41e-05	0.00014	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—lung cancer	4.41e-05	0.00014	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—lung cancer	4.38e-05	0.00014	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.36e-05	0.000609	CbGpPWpGaD
Rivastigmine—Malaise—Doxorubicin—lung cancer	4.34e-05	0.000138	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—lung cancer	4.32e-05	0.000138	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—lung cancer	4.32e-05	0.000138	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—lung cancer	4.32e-05	0.000137	CcSEcCtD
Rivastigmine—Diarrhoea—Docetaxel—lung cancer	4.31e-05	0.000137	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GNG11—lung cancer	4.29e-05	0.000599	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA1—lung cancer	4.27e-05	0.000596	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.27e-05	0.000596	CbGpPWpGaD
Rivastigmine—Palpitations—Doxorubicin—lung cancer	4.25e-05	0.000135	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—lung cancer	4.24e-05	0.000135	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—lung cancer	4.23e-05	0.000135	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ABCC3—lung cancer	4.22e-05	0.000589	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.22e-05	0.000589	CbGpPWpGaD
Rivastigmine—Cough—Doxorubicin—lung cancer	4.2e-05	0.000134	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—lung cancer	4.17e-05	0.000133	CcSEcCtD
Rivastigmine—Dizziness—Docetaxel—lung cancer	4.16e-05	0.000132	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—lung cancer	4.15e-05	0.000132	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—lung cancer	4.13e-05	0.000131	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—lung cancer	4.1e-05	0.000131	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—lung cancer	4.1e-05	0.00013	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—lung cancer	4.1e-05	0.00013	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—lung cancer	4.1e-05	0.00013	CcSEcCtD
Rivastigmine—BCHE—Metabolism—AKR1C1—lung cancer	4.09e-05	0.000571	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALDOA—lung cancer	4.09e-05	0.00057	CbGpPWpGaD
Rivastigmine—Anxiety—Doxorubicin—lung cancer	4.08e-05	0.00013	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—lung cancer	4.07e-05	0.00013	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.07e-05	0.000129	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—lung cancer	4.05e-05	0.000129	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—lung cancer	4.04e-05	0.000129	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—lung cancer	4.03e-05	0.000128	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—lung cancer	4.01e-05	0.000127	CcSEcCtD
Rivastigmine—Vomiting—Docetaxel—lung cancer	4e-05	0.000127	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—lung cancer	3.99e-05	0.000127	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.99e-05	0.000557	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ATP5H—lung cancer	3.98e-05	0.000555	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—UGT1A1—lung cancer	3.97e-05	0.000554	CbGpPWpGaD
Rivastigmine—Rash—Docetaxel—lung cancer	3.97e-05	0.000126	CcSEcCtD
Rivastigmine—ACHE—Metabolism—NCOA3—lung cancer	3.97e-05	0.000554	CbGpPWpGaD
Rivastigmine—Dermatitis—Docetaxel—lung cancer	3.96e-05	0.000126	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—POMC—lung cancer	3.96e-05	0.000553	CbGpPWpGaD
Rivastigmine—Confusional state—Doxorubicin—lung cancer	3.96e-05	0.000126	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—lung cancer	3.94e-05	0.000125	CcSEcCtD
Rivastigmine—Headache—Docetaxel—lung cancer	3.94e-05	0.000125	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.94e-05	0.000549	CbGpPWpGaD
Rivastigmine—Oedema—Doxorubicin—lung cancer	3.93e-05	0.000125	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—lung cancer	3.92e-05	0.000125	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—lung cancer	3.91e-05	0.000124	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—lung cancer	3.9e-05	0.000124	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.9e-05	0.000544	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—HRAS—lung cancer	3.89e-05	0.000543	CbGpPWpGaD
Rivastigmine—Pain—Methotrexate—lung cancer	3.88e-05	0.000123	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—lung cancer	3.86e-05	0.000123	CcSEcCtD
Rivastigmine—ACHE—Metabolism—ADCY1—lung cancer	3.86e-05	0.000539	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCG2—lung cancer	3.86e-05	0.000539	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP1—lung cancer	3.86e-05	0.000538	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Doxorubicin—lung cancer	3.85e-05	0.000123	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—lung cancer	3.85e-05	0.000122	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—lung cancer	3.83e-05	0.000122	CcSEcCtD
Rivastigmine—BCHE—Metabolism—GNG11—lung cancer	3.83e-05	0.000534	CbGpPWpGaD
Rivastigmine—Skin disorder—Doxorubicin—lung cancer	3.81e-05	0.000121	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.81e-05	0.000532	CbGpPWpGaD
Rivastigmine—Hyperhidrosis—Doxorubicin—lung cancer	3.8e-05	0.000121	CcSEcCtD
Rivastigmine—ACHE—Metabolism—ENO2—lung cancer	3.78e-05	0.000528	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HPGDS—lung cancer	3.78e-05	0.000528	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPP2R1B—lung cancer	3.76e-05	0.000525	CbGpPWpGaD
Rivastigmine—Anorexia—Doxorubicin—lung cancer	3.74e-05	0.000119	CcSEcCtD
Rivastigmine—Nausea—Docetaxel—lung cancer	3.74e-05	0.000119	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—lung cancer	3.74e-05	0.000119	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.71e-05	0.000518	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Methotrexate—lung cancer	3.71e-05	0.000118	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTT1—lung cancer	3.67e-05	0.000512	CbGpPWpGaD
Rivastigmine—Hypotension—Doxorubicin—lung cancer	3.67e-05	0.000117	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.67e-05	0.000512	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALDOA—lung cancer	3.65e-05	0.000509	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GCLC—lung cancer	3.63e-05	0.000506	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2A6—lung cancer	3.63e-05	0.000506	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.62e-05	0.000505	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.61e-05	0.000504	CbGpPWpGaD
Rivastigmine—Urticaria—Methotrexate—lung cancer	3.6e-05	0.000115	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—lung cancer	3.59e-05	0.000114	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—lung cancer	3.59e-05	0.000114	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.58e-05	0.000114	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.56e-05	0.000497	CbGpPWpGaD
Rivastigmine—Insomnia—Doxorubicin—lung cancer	3.55e-05	0.000113	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—PLBD1—lung cancer	3.54e-05	0.000495	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOA3—lung cancer	3.54e-05	0.000494	CbGpPWpGaD
Rivastigmine—Paraesthesia—Doxorubicin—lung cancer	3.53e-05	0.000112	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—lung cancer	3.5e-05	0.000111	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—lung cancer	3.49e-05	0.000111	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.48e-05	0.000485	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.48e-05	0.000485	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	3.47e-05	0.000484	CbGpPWpGaD
Rivastigmine—Dyspepsia—Doxorubicin—lung cancer	3.46e-05	0.00011	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ADCY1—lung cancer	3.44e-05	0.000481	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCG2—lung cancer	3.44e-05	0.000481	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP1—lung cancer	3.44e-05	0.00048	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ENO1—lung cancer	3.44e-05	0.00048	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.43e-05	0.000478	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.43e-05	0.000478	CbGpPWpGaD
Rivastigmine—Decreased appetite—Doxorubicin—lung cancer	3.41e-05	0.000109	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—lung cancer	3.39e-05	0.000108	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—lung cancer	3.39e-05	0.000108	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.38e-05	0.000472	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ENO2—lung cancer	3.38e-05	0.000471	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HPGDS—lung cancer	3.38e-05	0.000471	CbGpPWpGaD
Rivastigmine—Constipation—Doxorubicin—lung cancer	3.36e-05	0.000107	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—lung cancer	3.36e-05	0.000107	CcSEcCtD
Rivastigmine—BCHE—Metabolism—PPP2R1B—lung cancer	3.36e-05	0.000468	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Methotrexate—lung cancer	3.34e-05	0.000106	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.31e-05	0.000462	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTT1—lung cancer	3.27e-05	0.000457	CbGpPWpGaD
Rivastigmine—Asthenia—Methotrexate—lung cancer	3.25e-05	0.000104	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—HSD17B10—lung cancer	3.24e-05	0.000452	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2A6—lung cancer	3.24e-05	0.000452	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GCLC—lung cancer	3.24e-05	0.000452	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Doxorubicin—lung cancer	3.24e-05	0.000103	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.22e-05	0.00045	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Doxorubicin—lung cancer	3.21e-05	0.000102	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—lung cancer	3.21e-05	0.000102	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—POMC—lung cancer	3.21e-05	0.000448	CbGpPWpGaD
Rivastigmine—Urticaria—Doxorubicin—lung cancer	3.12e-05	9.93e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—lung cancer	3.1e-05	9.88e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—lung cancer	3.1e-05	9.88e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—lung cancer	3.1e-05	9.87e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—CYP2E1—lung cancer	3.09e-05	0.000431	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ENO1—lung cancer	3.07e-05	0.000428	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AZIN2—lung cancer	3.06e-05	0.000427	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.06e-05	0.000427	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.06e-05	0.000427	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NQO1—lung cancer	3.05e-05	0.000426	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.02e-05	0.000421	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CKB—lung cancer	3.01e-05	0.000421	CbGpPWpGaD
Rivastigmine—Dizziness—Methotrexate—lung cancer	3e-05	9.54e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.99e-05	0.000417	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP2—lung cancer	2.99e-05	0.000417	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—HRAS—lung cancer	2.98e-05	0.000416	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.96e-05	0.000413	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Doxorubicin—lung cancer	2.89e-05	9.21e-05	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—lung cancer	2.88e-05	9.18e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—POMC—lung cancer	2.86e-05	0.000399	CbGpPWpGaD
Rivastigmine—Rash—Methotrexate—lung cancer	2.86e-05	9.1e-05	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—lung cancer	2.86e-05	9.09e-05	CcSEcCtD
Rivastigmine—Headache—Methotrexate—lung cancer	2.84e-05	9.04e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—CNDP2—lung cancer	2.83e-05	0.000395	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM2—lung cancer	2.83e-05	0.000395	CbGpPWpGaD
Rivastigmine—Asthenia—Doxorubicin—lung cancer	2.82e-05	8.97e-05	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—lung cancer	2.78e-05	8.84e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—MTMR3—lung cancer	2.76e-05	0.000385	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2E1—lung cancer	2.75e-05	0.000384	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—STK11—lung cancer	2.75e-05	0.000384	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NQO1—lung cancer	2.72e-05	0.00038	CbGpPWpGaD
Rivastigmine—Nausea—Methotrexate—lung cancer	2.69e-05	8.57e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—lung cancer	2.69e-05	8.55e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—PGAM1—lung cancer	2.69e-05	0.000375	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.67e-05	0.000372	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP2—lung cancer	2.66e-05	0.000372	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—HRAS—lung cancer	2.66e-05	0.000371	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.64e-05	0.000369	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ATP5H—lung cancer	2.6e-05	0.000363	CbGpPWpGaD
Rivastigmine—Dizziness—Doxorubicin—lung cancer	2.6e-05	8.26e-05	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—POMC—lung cancer	2.59e-05	0.000362	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.58e-05	0.00036	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2A7—lung cancer	2.56e-05	0.000358	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—lung cancer	2.54e-05	0.000355	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SDC4—lung cancer	2.51e-05	0.00035	CbGpPWpGaD
Rivastigmine—Vomiting—Doxorubicin—lung cancer	2.5e-05	7.95e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—CXCL8—lung cancer	2.48e-05	0.000346	CbGpPWpGaD
Rivastigmine—Rash—Doxorubicin—lung cancer	2.48e-05	7.88e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—CAT—lung cancer	2.48e-05	0.000346	CbGpPWpGaD
Rivastigmine—Dermatitis—Doxorubicin—lung cancer	2.47e-05	7.87e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.46e-05	0.000344	CbGpPWpGaD
Rivastigmine—Headache—Doxorubicin—lung cancer	2.46e-05	7.83e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—STK11—lung cancer	2.45e-05	0.000342	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCB1—lung cancer	2.41e-05	0.000336	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TYMS—lung cancer	2.37e-05	0.00033	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTM1—lung cancer	2.34e-05	0.000326	CbGpPWpGaD
Rivastigmine—Nausea—Doxorubicin—lung cancer	2.33e-05	7.42e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—PLBD1—lung cancer	2.32e-05	0.000323	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.3e-05	0.000321	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA3—lung cancer	2.28e-05	0.000319	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—RRM1—lung cancer	2.28e-05	0.000319	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—lung cancer	2.27e-05	0.000317	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A1—lung cancer	2.22e-05	0.000309	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CXCL8—lung cancer	2.21e-05	0.000309	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CAT—lung cancer	2.21e-05	0.000308	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ERCC2—lung cancer	2.2e-05	0.000307	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.2e-05	0.000307	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCB1—lung cancer	2.15e-05	0.0003	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—B4GALT5—lung cancer	2.15e-05	0.0003	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD17B10—lung cancer	2.12e-05	0.000296	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TYMS—lung cancer	2.11e-05	0.000295	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA4—lung cancer	2.09e-05	0.000292	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—lung cancer	2.09e-05	0.000291	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA2—lung cancer	2.04e-05	0.000284	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A1—lung cancer	1.98e-05	0.000276	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CKB—lung cancer	1.97e-05	0.000275	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA1—lung cancer	1.96e-05	0.000274	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ERCC2—lung cancer	1.96e-05	0.000274	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCC3—lung cancer	1.94e-05	0.000271	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—APOA1—lung cancer	1.9e-05	0.000265	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKR1C1—lung cancer	1.88e-05	0.000262	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM2—lung cancer	1.85e-05	0.000259	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CNDP2—lung cancer	1.85e-05	0.000259	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—UGT1A1—lung cancer	1.83e-05	0.000255	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.82e-05	0.000254	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTMR3—lung cancer	1.8e-05	0.000252	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GNG11—lung cancer	1.76e-05	0.000246	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PGAM1—lung cancer	1.76e-05	0.000245	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CG—lung cancer	1.74e-05	0.000242	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—APOA1—lung cancer	1.7e-05	0.000237	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALDOA—lung cancer	1.68e-05	0.000234	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.68e-05	0.000234	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—POMC—lung cancer	1.65e-05	0.000231	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SDC4—lung cancer	1.64e-05	0.000229	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOA3—lung cancer	1.63e-05	0.000227	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.62e-05	0.000227	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CREBBP—lung cancer	1.61e-05	0.000225	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ADCY1—lung cancer	1.58e-05	0.000221	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCG2—lung cancer	1.58e-05	0.000221	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HPGDS—lung cancer	1.55e-05	0.000217	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ENO2—lung cancer	1.55e-05	0.000217	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CG—lung cancer	1.55e-05	0.000216	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.54e-05	0.000215	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CD—lung cancer	1.53e-05	0.000213	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALB—lung cancer	1.51e-05	0.00021	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—lung cancer	1.51e-05	0.00021	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RRM1—lung cancer	1.49e-05	0.000208	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA3—lung cancer	1.49e-05	0.000208	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GCLC—lung cancer	1.49e-05	0.000208	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2A6—lung cancer	1.49e-05	0.000208	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—POMC—lung cancer	1.47e-05	0.000206	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CREBBP—lung cancer	1.44e-05	0.0002	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ENO1—lung cancer	1.41e-05	0.000197	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.4e-05	0.000196	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA4—lung cancer	1.37e-05	0.000191	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CD—lung cancer	1.36e-05	0.00019	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALB—lung cancer	1.34e-05	0.000188	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA2—lung cancer	1.33e-05	0.000186	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CB—lung cancer	1.33e-05	0.000186	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—lung cancer	1.32e-05	0.000184	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA1—lung cancer	1.28e-05	0.000179	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCC3—lung cancer	1.27e-05	0.000177	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.27e-05	0.000177	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NQO1—lung cancer	1.25e-05	0.000175	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.23e-05	0.000172	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.19e-05	0.000167	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CB—lung cancer	1.19e-05	0.000166	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—lung cancer	1.18e-05	0.000164	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GNG11—lung cancer	1.15e-05	0.000161	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTEN—lung cancer	1.15e-05	0.00016	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—STK11—lung cancer	1.13e-05	0.000157	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—EP300—lung cancer	1.1e-05	0.000153	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALDOA—lung cancer	1.1e-05	0.000153	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOA3—lung cancer	1.06e-05	0.000148	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—lung cancer	1.04e-05	0.000146	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCG2—lung cancer	1.04e-05	0.000144	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ADCY1—lung cancer	1.04e-05	0.000144	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTEN—lung cancer	1.03e-05	0.000143	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CAT—lung cancer	1.02e-05	0.000142	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HPGDS—lung cancer	1.01e-05	0.000142	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ENO2—lung cancer	1.01e-05	0.000142	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.01e-05	0.000141	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCB1—lung cancer	9.88e-06	0.000138	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—lung cancer	9.84e-06	0.000137	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—EP300—lung cancer	9.78e-06	0.000137	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GCLC—lung cancer	9.73e-06	0.000136	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2A6—lung cancer	9.73e-06	0.000136	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TYMS—lung cancer	9.7e-06	0.000135	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—lung cancer	9.59e-06	0.000134	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ENO1—lung cancer	9.22e-06	0.000129	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A1—lung cancer	9.09e-06	0.000127	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ERCC2—lung cancer	9.02e-06	0.000126	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2E1—lung cancer	8.27e-06	0.000115	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NQO1—lung cancer	8.18e-06	0.000114	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—lung cancer	8.11e-06	0.000113	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—APOA1—lung cancer	7.8e-06	0.000109	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—STK11—lung cancer	7.37e-06	0.000103	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—lung cancer	7.24e-06	0.000101	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CG—lung cancer	7.12e-06	9.94e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—lung cancer	6.82e-06	9.52e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—POMC—lung cancer	6.78e-06	9.46e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CAT—lung cancer	6.64e-06	9.27e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—lung cancer	6.63e-06	9.25e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CREBBP—lung cancer	6.6e-06	9.22e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCB1—lung cancer	6.46e-06	9.02e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TYMS—lung cancer	6.34e-06	8.85e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—lung cancer	6.27e-06	8.75e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CD—lung cancer	6.26e-06	8.74e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALB—lung cancer	6.18e-06	8.63e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A1—lung cancer	5.94e-06	8.3e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—lung cancer	5.91e-06	8.25e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ERCC2—lung cancer	5.9e-06	8.23e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CB—lung cancer	5.46e-06	7.62e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—lung cancer	5.41e-06	7.55e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—APOA1—lung cancer	5.1e-06	7.12e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTEN—lung cancer	4.72e-06	6.58e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CG—lung cancer	4.66e-06	6.5e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—EP300—lung cancer	4.5e-06	6.28e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—POMC—lung cancer	4.43e-06	6.19e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CREBBP—lung cancer	4.32e-06	6.03e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CD—lung cancer	4.09e-06	5.71e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALB—lung cancer	4.04e-06	5.64e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CB—lung cancer	3.57e-06	4.98e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—lung cancer	3.54e-06	4.93e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—lung cancer	3.33e-06	4.64e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTEN—lung cancer	3.08e-06	4.3e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—EP300—lung cancer	2.94e-06	4.1e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—lung cancer	2.72e-06	3.79e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.17e-06	3.04e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—lung cancer	1.78e-06	2.48e-05	CbGpPWpGaD
